PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40125C00095Baa# fy25c3ap3 - hive 2.0: expansion — Dna Hive LLC

Dna Hive LLC holds $3.1M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 29, 2028 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Dna Hive LLC

Recipient

Sep 29, 2028

PoP end

$7.5M

Obligated

$7.5M

Potential

541714

NAICS

AN11

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract number75F40125C00095

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentDna Hive LLC

CAGE8B9Q6

UEIZULRXE8XYEM3

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11

Place of performanceROCKVILLE MD

Pricing typeCost No Fee

Extent competedFull And Open Competition

Related solicitationFDABAA-25-00123

PoP startSep 23, 2025

PoP end (current)Sep 29, 2028

Obligated$7.5M

Current value$7.5M

Potential value$7.5M

BAA# FY25C3AP3 - Hive 2.0: Expansion of FDA Argos is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by Dna Hive LLC. Estimated value $7.5M ($7.5M obligated). Current period of performance ends Sep 29, 2028. Last award drew 1 bidder. Place of performance: ROCKVILLE MD. Related solicitation FDABAA-25-00123.

Baa# fy25c3ap3 - hive 2.0: expansion of fda argos. Latest action is a modification.

Recompete timing

Public

● Expiring in 713 days

Current PoP ends Sep 29, 2028 (713 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 29, 2027.

Want the durability read on 75F40125C00095? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Dna Hive LLC — $3.1M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$3.1M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40125C00095?

75F40125C00095 (Baa# fy25c3ap3 - hive 2.0: expansion) is a Fda Office Of Acq Grant Svcs award with a potential value of $7.5M, currently held by Dna Hive LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40125C00095?

Fda Office Of Acq Grant Svcs awarded 75F40125C00095 to Dna Hive LLC (potential $7.5M).

Who is the incumbent on 75F40125C00095?

Dna Hive LLC is the incumbent with $3.1M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2028.

When does Dna Hive LLC’s 75F40125C00095 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40125C00095? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 3, 2026 · refreshed monthlyLatest procurement action Sep 24, 2026